技术服务

Services

发布日期:2025/3/23 4:00:50
上一篇:Value of SERCA2a as a Biomarker for the Identification of Patients With Advanced Heart Failure Requiring Circulatory Support 下一篇:Plasma and urine complement activation products in light chain and heavy chain deposition disease